RTI Biologics, Inc. 4

4 · RTI Biologics, Inc. · Filed Jun 2, 2008

Form 4

Period: 2008-05-29

Vice President

Transactions

Exercise/Conversion
Employee Stock Option (Right to Buy)
2008-05-29+2,000→ 3,000 total
Exercise: $6.33From: 2007-04-23Exp: 2016-10-23→ Common Stock (2,000 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2008-05-29+4,000→ 16,000 total
Exercise: $7.25From: 2008-03-02Exp: 2017-03-02→ Common Stock (4,000 underlying)
Sale
Common Stock
2008-05-29$9.66/sh−10,600$102,396→ 0 total
Exercise/Conversion
Common Stock
2008-05-29$6.33/sh+2,000$12,660→ 6,600 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2008-05-29+4,600→ 20,000 total
Exercise: $5.17From: 2007-08-23Exp: 2016-08-23→ Common Stock (4,600 underlying)
Exercise/Conversion
Common Stock
2008-05-29$5.17/sh+4,600$23,782→ 4,600 total
Exercise/Conversion
Common Stock
2008-05-29$7.25/sh+4,000$29,000→ 10,600 total

Footnotes (3)

[F1]Options vest 20% over 5 years starting the first year after the grant date. The options are fully exercisable on August 23, 2011.
[F2]Options vest 20% over 4 1/2 years starting the first year after grant date. The options are fully exercisable on April 23, 2011.
[F3]Options vest 20% over 5 years starting the first year after the grant date. The options are fully exercisable on March 2, 2012.

Documents

1 file